U.S. Markets closed

Blue Chip Drug Stocks Face 'Reckoning' on Future Downgrades

Blue Chip Drug Stocks Face 'Reckoning' on Future Downgrades

Shares of major drug makers including Pfizer Inc. (PFE), Eli Lilly & Co. (LLY), Amgen Inc. (AMGN), Novartis AG (NVS) and AbbVie Inc. (ABBV), are already dramatically lagging the broader market this year.